Preliminary research suggests that NG101, a drug from Neurogastrx, may lower the risk of nausea and vomiting in people taking ...
Mediaite on MSNOpinion
Credit Where It’s Due: Trump’s Weight-Loss Subsidy Is a Public-Health Game Changer
By subsidizing Wegovy and Zepbound, Trump may deliver one of the most consequential public-health interventions in decades.
Phase 2 data show significant reductions in nausea and vomiting that can cause patients to discontinue GLP-1s.
Investor's Business Daily on MSN
The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things.
Makers of weight-loss drugs saw their stocks surge in 2024, but no more. Now Trump's price deal adds new questions. Is the ...
A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...
A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...
The nausea and other gastrointestinal side effects of weight loss drugs like Novo Nordisk’s Wegovy or Eli Lilly’s Zepbound will limit how much these drugs can help patients and stunt the overall ...
President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.
The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.
Denmark-based Novo Nordisk, which makes Ozempic, Rybelsus and Wegovy; and Indianapolis-based Eli Lilly, which makes Zepbound, ...
A small study helps explain why some people taking Wegovy and similar weight-loss drugs cut back on alcohol, offering insight into potential new addiction therapies ...
This article was reviewed by Darragh O’Carroll, MD. GLP-1 for Weight Loss: Everything You Need to Know Key takeaways: GLP-1s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback